WAY-311677

CAS No. 19948-85-7

WAY-311677( —— )

Catalog No. M28996 CAS No. 19948-85-7

WAY-311677 has potential antiproliferative activity and is a FAK inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 68 In Stock
10MG 120 In Stock
25MG 255 In Stock
50MG 410 In Stock
100MG 605 In Stock
200MG 860 In Stock
500MG 1287 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-311677
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-311677 has potential antiproliferative activity and is a FAK inhibitor.
  • Description
    WAY-311677 has potential antiproliferative activity and is a FAK inhibitor.
  • In Vitro
    FAK-IN-7 (0-10 μM; 48 h) inhibits MCF-7 and B16-F10 cells proliferation.Cell Proliferation Assay Cell Line:MCF-7 and B16-F10 cells Concentration:0-10 μM Incubation Time:48 h Result:Exhibited anti-proliferative activity against MCF-7 and B16-F10 cells with IC50 values of 3.57 and 3.52 μM, respectively.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    FAK
  • Recptor
    FAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19948-85-7
  • Formula Weight
    295.36
  • Molecular Formula
    C16H13N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (33.86 mM)
  • SMILES
    O=C(C1=CC=CC=C1)NC2=NN=C(C3=CC=C(C)C=C3)S2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Defactinib

    Defactinib (VS-6063, PF-04554878) is a potent, selective and orally active FAK inhibitor, selectively inhibits pFAK (Tyr397) in a dose-dependent manner in cancer cell lines.

  • Ifebemtinib

    Ifebemtinib (BI-853520) is an orally active and potent inhibitor of adhesion plaque kinase (FAK) (IC50=1 nM) with anti-tumour activity that inhibits globule formation and in situ tumour growth in malignant pleural mesotheliomas.

  • Compound 1T-0219 (SC...

    Compound 1T-0219 (SC) is a blocker of AKT1-FAK interaction reducing the stimulation of FAK phosphorylation in response to extracellular pressure in human SW620 colon cancer cells without affecting basal FAK phosphorylation.